In the fiscal year 2018, the number of approved in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan amounted to 153, up from 147 approved products in fiscal 2012. PMDA functions as a regulatory agency for pharmaceutical products and medical devices, working together with the health ministry in Japan.
Number of in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal year 2012 to 2018
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Approval number quasi-drugs Japan FY 2012-2018
- Approval number BTC and OTC drugs Japan FY 2012-2018
- Approval number prescription drugs Japan FY 2012-2018
- Number of NME approved Japan 2010-2019
- Number of biological drugs approved Japan 2010-2019
- Number of biosimilars approved by PMDA Japan 2010-2019
- Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- Hanmi Pharmaceutical R&D investment 2017-2019
- Revenue of the pharmaceutical industry in Italy 2018, by sector
- Turnover of the manufacture of pharmaceutical products in Finland 2010-2017
- Quasi-drugs production plants in Japan 2016, by region
- Breakdown of quasi-drugs production in Japan 2016, by region
- Takeda Pharmaceutical's expenditure on R&D FY 2011-2019
- Expected impact of Brexit on attractiveness of pharmaceutical market in the UK 2018
PMDA. (November 26, 2019). Number of in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal year 2012 to 2018 [Graph]. In Statista. Retrieved March 06, 2021, from https://www.statista.com/statistics/827328/japan-pmda-number-approved-in-vitro-diagnostics/
PMDA. "Number of in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal year 2012 to 2018." Chart. November 26, 2019. Statista. Accessed March 06, 2021. https://www.statista.com/statistics/827328/japan-pmda-number-approved-in-vitro-diagnostics/
PMDA. (2019). Number of in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal year 2012 to 2018. Statista. Statista Inc.. Accessed: March 06, 2021. https://www.statista.com/statistics/827328/japan-pmda-number-approved-in-vitro-diagnostics/
PMDA. "Number of In-vitro Diagnostics Approved by The Pharmaceuticals and Medical Devices Agency (Pmda) in Japan from Fiscal Year 2012 to 2018." Statista, Statista Inc., 26 Nov 2019, https://www.statista.com/statistics/827328/japan-pmda-number-approved-in-vitro-diagnostics/
PMDA, Number of in-vitro diagnostics approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan from fiscal year 2012 to 2018 Statista, https://www.statista.com/statistics/827328/japan-pmda-number-approved-in-vitro-diagnostics/ (last visited March 06, 2021)